-   comment: Mesalazine is the active moiety of sulfasalazine, which is metabolized to sulfapyridine and mesalazine.
    directed: true
    graph:
        disease: Ulcerative colitis
        disease_mesh: MESH:D003093
        drug: Mesalazine
        drug_mesh: MESH:D019804
        drugbank: DB:DB00244
    links:
    -   key: decreases activity of
        source: MESH:D019804
        target: UniProt:P23219
    -   key: decreases activity of
        source: MESH:D019804
        target: UniProt:P35354
    -   key: decreases activity of
        source: MESH:D019804
        target: UniProt:P09917
    -   key: increases activity of
        source: MESH:D019804
        target: UniProt:P37231
    -   key: increases abundance of
        source: UniProt:P23219
        target: MESH:D011453
    -   key: increases abundance of
        source: UniProt:P35354
        target: MESH:D011453
    -   key: increases abundance of
        source: UniProt:P09917
        target: MESH:D015289
    -   key: negatively regulates
        source: UniProt:P37231
        target: GO:0038061
    -   key: positively regulates
        source: MESH:D011453
        target: GO:0006954
    -   key: positively regulates
        source: MESH:D015289
        target: GO:0006954
    -   key: positively regulates
        source: GO:0038061
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: MESH:D003093
    multigraph: true
    nodes:
    -   id: MESH:D019804
        label: Drug
        name: Mesalazine
    -   id: UniProt:P23219
        label: Protein
        name: Prostaglandin G/H synthase 1
    -   id: UniProt:P35354
        label: Protein
        name: Prostaglandin G/H synthase 2
    -   id: UniProt:P09917
        label: Protein
        name: Polyunsaturated fatty acid 5-lipoxygenase 
    -   id: UniProt:P37231
        label: Protein
        name: Peroxisome proliferator-activated receptor gamma
    -   id: MESH:D011453
        label: ChemicalSubstance
        name: Prostaglandins
    -   id: MESH:D015289
        label: ChemicalSubstance
        name: Leukotrienes
    -   id: GO:0038061
        label: BiologicalProcess
        name: NIK/NF-kappaB signaling
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D003093
        label: Disease
        name: Ulcerative colitis
    reference: https://go.drugbank.com/drugs/DB00244#BE0000248
       https://link.springer.com/article/10.1186/s13020-020-0296-z https://www.uniprot.org/uniprot/P37231
-   directed: true
    graph:
        disease: Atopic dermatitis
        disease_mesh: MESH:D003876
        drug: Pimecrolimus
        drug_mesh: MESH:C117268
        drugbank: DB:DB00337
    links:
    -   key: decreases activity of
        source: MESH:C117268
        target: UniProt:Q08209
    -   key: negatively regulates
        source: MESH:C117268
        target: GO:0043303
    -   key: positively regulates
        source: UniProt:Q08209
        target: GO:0032623
    -   key: positively correlated with
        source: GO:0043303
        target: GO:0006954
    -   key: positively regulates
        source: GO:0032623
        target: GO:0042110
    -   key: positively correlated with
        source: GO:0042110
        target: GO:0006955
    -   key: causes
        source: GO:0006954
        target: MESH:D003876
    -   key: positively correlated with
        source: GO:0006955
        target: MESH:D003876
    multigraph: true
    nodes:
    -   id: MESH:C117268
        label: Drug
        name: Pimecrolimus
    -   id: UniProt:Q08209
        label: Protein
        name: Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform
    -   id: GO:0043303
        label: BiologicalProcess
        name: Mast cell degranulation
    -   id: GO:0032623
        label: BiologicalProcess
        name: Interleukin-2 production
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: GO:0042110
        label: BiologicalProcess
        name: T cell activation
    -   id: GO:0006955
        label: BiologicalProcess
        name: Immune response
    -   id: MESH:D003876
        label: Disease
        name: Atopic dermatitis
    reference: https://en.wikipedia.org/wiki/Pimecrolimus https://go.drugbank.com/drugs/DB00337
        https://en.wikipedia.org/wiki/Immunosuppressive_drug#Drugs_acting_on_immunophilins
-   directed: true
    graph:
        disease: Human immunodeficiency virus infection
        disease_mesh: MESH:D015658
        drug: Delavirdine
        drug_mesh: MESH:D020008
        drugbank: DB:DB00705
    links:
    -   key: decreases activity of
        source: MESH:D020008
        target: UniProt:Q72547
    -   key: positively regulates
        source: UniProt:Q72547
        target: GO:0001171
    -   key: positively correlated with
        source: GO:0001171
        target: GO:0019079
    -   key: in taxon
        source: GO:0019079
        target: NCBITaxon:11676
    -   key: causes
        source: NCBITaxon:11676
        target: MESH:D015658
    multigraph: true
    nodes:
    -   id: MESH:D020008
        label: Drug
        name: Delavirdine
    -   id:  UniProt:Q72547
        label: Protein
        name: Reverse transcriptase/RNaseH
    -   id: GO:0001171
        label: BiologicalProcess
        name: Reverse transcription
    -   id: GO:0019079
        label: BiologicalProcess
        name: Viral genome replication
    -   id: NCBITaxon:11676
        label: OrganismTaxon
        name: Human immunodeficiency virus 1
    -   id: MESH:D015658
        label: Disease
        name: Human immunodeficiency virus infection
    reference: https://go.drugbank.com/drugs/DB00705
-   comment: Phytomenadione promotes calcification of bones and teeth and can be supplemented together with calcium sources in cases of hypocalcemia.
       Additionally phytomenadione may prevent arterial calcification in case of calcium supplementation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566462/
    directed: true
    graph:
        disease: Hypocalcemia
        disease_mesh: MESH:D006996
        drug: Phytomenadione
        drug_mesh: MESH:D014812
        drugbank: DB:DB01022
    links:
    -   key: increases activity of
        source: MESH:D014812
        target: UniProt:P02818
    -   key: positively regulates
        source: UniProt:P02818
        target: GO:0030282
    -   key: negatively correlated with
        source: GO:0030282
        target: MESH:D006996
    multigraph: true
    nodes:
    -   id: MESH:D014812
        label: Drug
        name: Phytomenadione
    -   id: UniProt:P02818
        label: Protein
        name: Osteocalcin
    -   id: GO:0030282
        label: BiologicalProcess
        name: Bone mineralization
    -   id: MESH:D006996
        label: Disease
        name: Hypocalcemia
    reference: https://go.drugbank.com/drugs/DB01022 https://pubmed.ncbi.nlm.nih.gov/3530901/ https://en.wikipedia.org/wiki/Hypocalcemia
-   comment: Phytomenadione promotes calcification of bones and can be supplemented together with calcium sources in cases of postmenopausal osteoporosis.
       Additionally phytomenadione may prevent arterial calcification in case of calcium supplementation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566462/
    directed: true
    graph:
        disease: Postmenopausal osteoporosis
        disease_mesh: MESH:D015663
        drug: Phytomenadione
        drug_mesh: MESH:D014812
        drugbank: DB:DB01022
    links:
    -   key: increases activity of
        source: MESH:D014812
        target: UniProt:P02818
    -   key: positively regulates
        source: UniProt:P02818
        target: GO:0030282
    -   key: negatively correlated with
        source: GO:0030282
        target: MESH:D015663
    multigraph: true
    nodes:
    -   id: MESH:D014812
        label: Drug
        name: Phytomenadione
    -   id: UniProt:P02818
        label: Protein
        name: Osteocalcin
    -   id: GO:0030282
        label: BiologicalProcess
        name: Bone mineralization
    -   id: MESH:D015663
        label: Disease
        name: Postmenopausal osteoporosis
    reference: https://go.drugbank.com/drugs/DB01022 https://pubmed.ncbi.nlm.nih.gov/3530901/
-   comment: Phytomenadione promotes calcification of bones and can be supplemented together with calcium sources in cases of postmenopausal osteoporosis.
       Additionally phytomenadione may prevent arterial calcification in case of calcium supplementation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566462/
    directed: true
    graph:
        disease: Osteoporosis
        disease_mesh: MESH:D010024
        drug: Phytomenadione
        drug_mesh: MESH:D014812
        drugbank: DB:DB01022
    links:
    -   key: increases activity of
        source: MESH:D014812
        target: UniProt:P02818
    -   key: positively regulates
        source: UniProt:P02818
        target: GO:0030282
    -   key: negatively correlated with
        source: GO:0030282
        target: MESH:D010024
    multigraph: true
    nodes:
    -   id: MESH:D014812
        label: Drug
        name: Phytomenadione
    -   id: UniProt:P02818
        label: Protein
        name: Osteocalcin
    -   id: GO:0030282
        label: BiologicalProcess
        name: Bone mineralization
    -   id: MESH:D010024
        label: Disease
        name: Osteoporosis
    reference: https://go.drugbank.com/drugs/DB01022 https://pubmed.ncbi.nlm.nih.gov/3530901/
-   comments: Although the mechanism of action has not been determined, orphenadrine appears to be a nonselective muscarinic antagonist https://en.wikipedia.org/wiki/Orphenadrine#Pharmacology
      Parkinsonian syndromes are often the consequence of a disturbed balance between cholinergic and dopaminergic neurotransmission
      in the basal ganglia caused by a decrease in dopamine. Muscarinic antagonists restore the physiological equilibrium and has a favourable effect
      on the rigidity and tremor of and Parkinsonian syndromes https://www.cell.com/neuron/fulltext/S0896-6273(19)30563-X. 
    directed: true
    graph:
        disease: Parkinsonism
        disease_mesh: MESH:D020734
        drug: Orphenadrine
        drug_mesh: MESH:D009966
        drugbank: DB:DB01173
    links:
    -   key: negatively regulates
        source: MESH:D009966
        target: REACT:R-HSA-390648
    -   key: positively regulates
        source: REACT:R-HSA-390648
        target: GO:0007271
    -   key: positively correlated with
        source: GO:0007271
        target: MESH:D020734
    multigraph: true
    nodes:
    -   id: MESH:D009966
        label: Drug
        name: Orphenadrine
    -   id: REACT:R-HSA-390648
        label: Pathway
        name: Muscarinic acetylcholine receptors
    -   id: GO:0007271
        label: BiologicalProcess
        name: Synaptic transmission, cholinergic
    -   id: MESH:D020734
        label: Disease
        name: Parkinsonism
    reference: https://go.drugbank.com/drugs/DB01173 https://en.wikipedia.org/wiki/Parkinsonism
-   comment: Orphenadrine works centrally and interferes with reflex pathways for pain and skeletal muscle contraction. The precise mechanism of action of orphenadrine is not known,
          but it appears to indirectly relieve muscle spasm through central atropine-like effects, although its mild antihistaminic activity may have a role.
    directed: true
    graph:
        disease: Spasticity
        disease_mesh: MESH:D009128
        drug: Orphenadrine
        drug_mesh: MESH:D009966
        drugbank: DB:DB01173
    links:
    -   key: treats
        source: MESH:D009966
        target: MESH:D009128
    multigraph: true
    nodes:
    -   id: MESH:D009966
        label: Drug
        name: Orphenadrine
    -   id: MESH:D009128
        label: Disease
        name: Spasticity
    reference: https://go.drugbank.com/drugs/DB01173#BE0000396 https://pubmed.ncbi.nlm.nih.gov/1864455/ https://pubmed.ncbi.nlm.nih.gov/25050056/
-   directed: true
    graph:
        disease: Staphylococcal pneumonia
        disease_mesh: MESH:D011023
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:1279
    -   key: causes
        source: NCBITaxon:1279
        target: MESH:D011023
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:1279
        label: OrganismTaxon
        name: Staphylococcus
    -   id: MESH:D011023
        label: Disease
        name: Staphylococcal pneumonia
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Infectious disease of abdomen
        disease_mesh: MESH:D059413
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:2
    -   key: causes
        source: NCBITaxon:2
        target: MESH:D059413
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:2
        label: OrganismTaxon
        name: Bacteria
    -   id: MESH:D059413
        label: Disease
        name: Infectious disease of abdomen
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Infection due to Escherichia coli
        disease_mesh: MESH:D004927
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:562
    -   key: causes
        source: NCBITaxon:562
        target: MESH:D004927
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:562
        label: OrganismTaxon
        name: Escherichia coli
    -   id: MESH:D004927
        label: Disease
        name: Infection due to Escherichia coli
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Infection due to Staphylococcus aureus
        disease_mesh: MESH:D013203
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:1280
    -   key: causes
        source: NCBITaxon:1280
        target: MESH:D013203
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:1280
        label: OrganismTaxon
        name: Staphylococcus aureus
    -   id: MESH:D013203
        label: Disease
        name: Infection due to Staphylococcus aureus
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Urinary tract infectious disease
        disease_mesh: MESH:D014552
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:2
    -   key: causes
        source: NCBITaxon:2
        target: MESH:D014552
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:2
        label: OrganismTaxon
        name: Bacteria
    -   id: MESH:D014552
        label: Disease
        name: Urinary tract infectious disease
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Streptococcus pyogenes infection
        disease_mesh: MESH:D013290
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:1314
    -   key: causes
        source: NCBITaxon:1314
        target: MESH:D013290
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:1314
        label: OrganismTaxon
        name: Streptococcus pyogenes
    -   id: MESH:D013290
        label: Disease
        name: Streptococcus pyogenes infection
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Infection due to Enterobacteriaceae
        disease_mesh: MESH:D004756
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:543
    -   key: causes
        source: NCBITaxon:543
        target: MESH:D004756
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:543
        label: OrganismTaxon
        name: Enterobacteriaceae
    -   id: MESH:D004756
        label: Disease
        name: Infection due to Enterobacteriaceae
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Pneumonia
        disease_mesh: MESH:D011014
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:2
    -   key: causes
        source: NCBITaxon:2
        target: MESH:D011014
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:2
        label: OrganismTaxon
        name: Bacteria
    -   id: MESH:D011014
        label: Disease
        name: Pneumonia
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Pneumonia due to Streptococcus
        disease_mesh: MESH:D011018
        drug: Cefamandole
        drug_mesh: MESH:D002435
        drugbank: DB:DB01326
    links:
    -   key: decreases activity of
        source: MESH:D002435
        target: InterPro:IPR001460
    -   key: positively regulates
        source: InterPro:IPR001460
        target: GO:0018104
    -   key: positively regulates
        source: GO:0018104
        target: GO:0009273
    -   key: has output
        source: GO:0009273
        target: GO:0005618
    -   key: occurs in
        source: GO:0005618
        target: NCBITaxon:1313
    -   key: causes
        source: NCBITaxon:1313
        target: MESH:D011018
    multigraph: true
    nodes:
    -   id: MESH:D002435
        label: Drug
        name: Cefamandole
    -   id: InterPro:IPR001460
        label: GeneFamily
        name: Penicillin-binding protein, transpeptidase
    -   id: GO:0018104
        label: BiologicalProcess
        name: Cross-linking of the peptidoglycan
    -   id: GO:0009273
        label: BiologicalProcess
        name: Peptidoglycan-based cell wall biogenesis
    -   id: GO:0005618
        label: CellularComponent
        name: Cell wall
    -   id: NCBITaxon:1313
        label: OrganismTaxon
        name: Streptococcus pneumoniae
    -   id: MESH:D011018
        label: Disease
        name: Pneumonia due to Streptococcus
    reference: https://go.drugbank.com/drugs/DB01326
-   directed: true
    graph:
        disease: Schizophrenia
        disease_mesh: MESH:D012559
        drug: Asenapine
        drug_mesh: MESH:C522667
        drugbank: DB:DB06216
    links:
    -   key: decreases activity of
        source: MESH:C522667
        target: UniProt:P28223
    -   key: decreases activity of
        source: MESH:C522667
        target: UniProt:P14416
    -   key: positively correlated with
        source: UniProt:P28223
        target: HP:0000716
    -   key: positively correlated with
        source: UniProt:P14416
        target: REACT:R-HSA-390651
    -   key: occurs in
        source: HP:0000716
        target: MESH:D012559
    -   key: correlated with
        source: REACT:R-HSA-390651
        target: MESH:D012559
    multigraph: true
    nodes:
    -   id: MESH:C522667
        label: Drug
        name: Asenapine
    -   id: UniProt:P28223
        label: Protein
        name: 5-hydroxytryptamine receptor 2A
    -   id: UniProt:P14416
        label: Protein
        name: D(2) dopamine receptor
    -   id: HP:0000716
        label: PhenotypicFeature
        name: Depressivity
    -   id: REACT:R-HSA-390651
        label: Pathway
        name: Dopamine receptors
    -   id: MESH:D012559
        label: Disease
        name: Schizophrenia
    reference: https://pubmed.ncbi.nlm.nih.gov/27356921/ https://go.drugbank.com/drugs/DB06216#BE0000451 https://en.wikipedia.org/wiki/5-HT2A_receptor
-   directed: true
    graph:
        disease: Respiratory distress syndrome in the newborn
        disease_mesh: MESH:D012127
        drug: Tyloxapol
        drug_mesh: MESH:C016811
        drugbank: DB:DB06439
    links:
    -   key: capable of
        source: MESH:C016811
        target: GO:0043129
    -   key: negatively correlated with
        source: GO:0043129
        target: MESH:D012127
    multigraph: true
    nodes:
    -   id: MESH:C016811
        label: Drug
        name: Tyloxapol
    -   id: GO:0043129
        label: BiologicalProcess
        name: Surfactant homeostasis
    -   id: MESH:D012127
        label: Disease
        name: Respiratory distress syndrome in the newborn
    reference: https://go.drugbank.com/drugs/DB06439 https://en.wikipedia.org/wiki/Infant_respiratory_distress_syndrome https://en.wikipedia.org/wiki/Tyloxapol
-   comment: Withdrawn. The mechanism of action of aurothioglucose is not well elucidated.
    directed: true
    graph:
        disease: Rheumatoid arthritis
        disease_mesh: MESH:D001172
        drug: Aurothioglucose
        drug_mesh: MESH:D006051
        drugbank: DB:DB09121
    links:
    -   key: negatively regulates
        source: MESH:D006051
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: MESH:D001172
    multigraph: true
    nodes:
    -   id: MESH:D006051
        label: Drug
        name: Aurothioglucose
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D001172
        label: Disease
        name: Rheumatoid arthritis
    reference: https://go.drugbank.com/drugs/DB09121 https://en.wikipedia.org/wiki/Gold_salts#Mechanism_in_arthritis
-   comment: Withdrawn. The mechanism of action of aurothioglucose is not well elucidated.
    directed: true
    graph:
        disease: Juvenile rheumatoid arthritis
        disease_mesh: MESH:D001171
        drug: Aurothioglucose
        drug_mesh: MESH:D006051
        drugbank: DB:DB09121
    links:
    -   key: negatively regulates
        source: MESH:D006051
        target: GO:0006954
    -   key: positively correlated with
        source: GO:0006954
        target: MESH:D001171
    multigraph: true
    nodes:
    -   id: MESH:D006051
        label: Drug
        name: Aurothioglucose
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D001171
        label: Disease
        name: Juvenile rheumatoid arthritis
    reference: https://go.drugbank.com/drugs/DB09121 https://en.wikipedia.org/wiki/Gold_salts#Mechanism_in_arthritis
-   directed: true
    graph:
        disease: Congestive heart failure
        disease_mesh: MESH:D006333
        drug: Ubidecarenone
        drug_mesh: MESH:C010524
        drugbank: DB:DB09270
    links:
    -   key: increases activity of
        source: MESH:C010524
        target: UniProt:P56181
    -   key: increases activity of
        source: MESH:C010524
        target: UniProt:P31040
    -   key: positively regulates
        source: UniProt:P56181
        target: GO:0042773
    -   key: positively regulates
        source: UniProt:P31040
        target: GO:0042773
    -   key: increases abundance of
        source: GO:0042773
        target: CHEBI:15422
    -   key: participates in
        source: CHEBI:15422
        target: GO:0060047
    -   key: negatively correlated with
        source: GO:0060047
        target: MESH:D006333
    multigraph: true
    nodes:
    -   id: MESH:C010524
        label: Drug
        name: Ubidecarenone
    -   id: UniProt:P56181
        label: Protein
        name: NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial
    -   id: UniProt:P31040
        label: Protein
        name: Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
    -   id: GO:0042773
        label: BiologicalProcess
        name: ATP synthesis coupled electron transport
    -   id: CHEBI:15422
        label: ChemicalSubstance
        name: ATP
    -   id: GO:0060047
        label: BiologicalProcess
        name: Heart contraction
    -   id: MESH:D006333
        label: Drug
        name: Congestive heart failure
    reference: https://go.drugbank.com/drugs/DB09270#BE0000176
